Roudbary S, Yousefzadeh-Chabok S, Behzadnia H, Bakhshayesh-Eghbali B, Emamhadi M, Ghayeghran A, et al . Non-adherence to Disease-Modifying Treatments in Patients with Multiple Sclerosis. Caspian J Neurol Sci 2017; 3 (3) :128-134
URL:
http://cjns.gums.ac.ir/article-1-178-fa.html
چکیده: (5068 مشاهده)
Background: Multiple Sclerosis (MS) is a debilitating disease of the central nervous system. Usually, long-term MS medications are injected intramuscularly or subcutaneously, making them intolerable for many MS patients.
Objectives: In the present study, the rate and the causes of non-adherence to MS disease-modifying drugs (DMDs) were assessed in patients with MS.
Materials and Methods: Two hundred and three MS patients of Guilan MS Society were interviewed demographic and clinical data of the patients were collected.
Results: Among the 203 patients, 73.9% were female. The mean±SD age of the patients was 32.47±9.15. Non-adherence to DMDs was due to side effects (21.7%) and requests of the families (21.7%) or ineffectiveness (17.4%). Significant association was seen between the non-adherence to DMDs and gender (p=0.015) and relapses (p=0.021).
Conclusion: The evidence from the present study suggests that there is a high rate of non-adherence to DMDs in MS patients in Guilan.
نوع مطالعه:
پژوهشي |
موضوع مقاله:
تخصصي دریافت: 1396/5/6 | پذیرش: 1396/5/6 | انتشار: 1396/5/6